Canrenoic acid: Difference between revisions

Canrenoic acid
	File:Canrenoic acid.svg
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 11:47, 15 February 2025

A potassium-sparing diuretic drug

Canrenoic acid is a pharmaceutical drug that acts as a potassium-sparing diuretic. It is primarily used in the treatment of conditions such as congestive heart failure, hypertension, and edema.

Pharmacology[edit]

Canrenoic acid is a prodrug of canrenone, which is an active metabolite. It works by antagonizing the effects of aldosterone, a hormone that promotes the retention of sodium and water in the body. By inhibiting aldosterone, canrenoic acid helps to increase the excretion of sodium and water while retaining potassium, thus acting as a diuretic.

Mechanism of Action[edit]

File:Canrenoic acid.svg

Chemical structure of canrenoic acid

Canrenoic acid binds to the mineralocorticoid receptor in the kidney, preventing aldosterone from exerting its effects. This leads to increased excretion of sodium and water, while potassium is retained, which is beneficial in conditions where potassium loss is a concern.

Clinical Uses[edit]

Canrenoic acid is used in the management of:

Congestive heart failure
Hypertension
Edema associated with liver cirrhosis or nephrotic syndrome

Side Effects[edit]

Common side effects of canrenoic acid include:

Hyperkalemia (elevated potassium levels)
Hyponatremia (low sodium levels)
Gastrointestinal disturbances

Contraindications[edit]

Canrenoic acid should not be used in patients with:

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Canrenoic acid''' is a synthetic [[steroid]] and a derivative of [[spironolactone]]. It is primarily used in the field of [[medicine]] as a [[potassium-sparing diuretic]], which means it promotes the excretion of water and sodium from the body, while retaining potassium.
+{{Short description|A potassium-sparing diuretic drug}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Canrenoic_acid.svg
+| image2 = <!-- Another image if available -->
+}}
-==Chemical Structure==
+'''Canrenoic acid''' is a [[pharmaceutical drug]] that acts as a [[potassium-sparing diuretic]]. It is primarily used in the treatment of conditions such as [[congestive heart failure]], [[hypertension]], and [[edema]].
-Canrenoic acid is a steroidal compound, which means it has a structure based on a specific arrangement of four interconnected [[carbon]] rings. The chemical formula of canrenoic acid is C22H28O3. It is a derivative of spironolactone, which means it is structurally similar to this compound but has been chemically modified.
 ==Pharmacology==
-As a potassium-sparing diuretic, canrenoic acid works by inhibiting the actions of [[aldosterone]], a hormone that promotes the retention of sodium and water in the body. By blocking the effects of aldosterone, canrenoic acid promotes the excretion of sodium and water, while preventing the loss of potassium. This makes it useful in the treatment of conditions such as [[hypertension]] (high blood pressure) and [[edema]] (fluid retention).
+Canrenoic acid is a prodrug of [[canrenone]], which is an active metabolite. It works by antagonizing the effects of [[aldosterone]], a hormone that promotes the retention of sodium and water in the body. By inhibiting aldosterone, canrenoic acid helps to increase the excretion of sodium and water while retaining potassium, thus acting as a diuretic.
-==Clinical Use==
+==Mechanism of Action==
-Canrenoic acid is used in the treatment of various conditions that are characterized by fluid retention or high blood pressure. These include [[congestive heart failure]], liver cirrhosis with ascites and swelling (edema), and nephrotic syndrome. It is also used in the treatment of primary hyperaldosteronism, a condition characterized by excessive production of aldosterone.
+[[File:Canrenoic_acid.svg|thumb|right|Chemical structure of canrenoic acid]]
+Canrenoic acid binds to the [[mineralocorticoid receptor]] in the [[kidney]], preventing aldosterone from exerting its effects. This leads to increased excretion of sodium and water, while potassium is retained, which is beneficial in conditions where potassium loss is a concern.
+==Clinical Uses==
+Canrenoic acid is used in the management of:
+* [[Congestive heart failure]]
+* [[Hypertension]]
+* [[Edema]] associated with [[liver cirrhosis]] or [[nephrotic syndrome]]
 ==Side Effects==
-Like all medications, canrenoic acid can cause side effects. These may include [[hyperkalemia]] (high potassium levels in the blood), [[hyponatremia]] (low sodium levels in the blood), and [[gynecomastia]] (enlargement of the breasts in men). It can also cause menstrual irregularities in women.
+Common side effects of canrenoic acid include:
+* [[Hyperkalemia]] (elevated potassium levels)
+* [[Hyponatremia]] (low sodium levels)
+* [[Gastrointestinal disturbances]]
+==Contraindications==
+Canrenoic acid should not be used in patients with:
+* [[Hyperkalemia]]
+* Severe [[renal impairment]]
+* [[Addison's disease]]
-==See Also==
+==Related pages==
+* [[Diuretics]]
+* [[Aldosterone antagonist]]
 * [[Spironolactone]]
-* [[Potassium-sparing diuretic]]
-* [[Aldosterone]]
-[[Category:Medicine]]
-[[Category:Pharmacology]]
 [[Category:Diuretics]]
-{{medicine-stub}}
+[[Category:Potassium-sparing diuretics]]
+[[Category:Aldosterone antagonists]]